Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of roxadustat in hemodialysis CKD anemia converted from ESA
NCT02779764Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- May 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roxadustat in anemia of chronic kidney disease (CKD-A), sponsored by Astellas Pharma. Started May 2016; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02779764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02779764.